{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:36:25Z","timestamp":1789212985868,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41417-026-01044-5","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:50:57Z","timestamp":1780411857000},"page":"795-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity"],"prefix":"10.1038","volume":"33","author":[{"given":"Yiran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5558-2820","authenticated-orcid":false,"given":"Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.3390\/ijerph19159059","volume":"19","author":"N Abdol Manap","year":"2022","unstructured":"Abdol Manap N, Ng BK, Phon SE, Abdul Karim AK, Lim PS, Fadhil M. Endometrial cancer in pre-menopausal women and younger: risk factors and outcome. Int J Environ Res Public Health. 2022;19:9059.","journal-title":"Int J Environ Res Public Health"},{"key":"1044_CR2","doi-asserted-by":"publisher","first-page":"e080978.","DOI":"10.1136\/bmj-2024-080978","volume":"388","author":"BR Corr","year":"2025","unstructured":"Corr BR, Erickson BK, Barber EL, Fisher CM, Slomovitz B. Advances in the management of endometrial cancer. bmj. 2025;388:e080978.","journal-title":"bmj"},{"key":"1044_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03851-4","volume":"21","author":"P Huang","year":"2023","unstructured":"Huang P, Fan X, Yu H, Zhang K, Li H, Wang Y, et al. Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer. J Transl Med. 2023;21:94.","journal-title":"J Transl Med"},{"key":"1044_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/cancers16051028","volume":"16","author":"H Baker-Rand","year":"2024","unstructured":"Baker-Rand H, Kitson SJ. Recent advances in endometrial cancer prevention, early diagnosis and treatment. Cancers. 2024;16:1028.","journal-title":"Cancers"},{"key":"1044_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.6004\/jadpro.2022.13.1.4","volume":"13","author":"K Halla","year":"2022","unstructured":"Halla K. Emerging treatment options for advanced or recurrent endometrial cancer. J Adv Pract Oncol. 2022;13:45.","journal-title":"J Adv Pract Oncol"},{"key":"1044_CR6","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 2023;97:1439\u201351.","journal-title":"Arch Toxicol"},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"1044_CR8","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/antiox11122444","volume":"11","author":"J Lee","year":"2022","unstructured":"Lee J, Roh J-L. SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer. Antioxidants. 2022;11:2444.","journal-title":"Antioxidants"},{"key":"1044_CR9","doi-asserted-by":"publisher","first-page":"e33478","DOI":"10.1097\/MD.0000000000033478","volume":"102","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou L, Dong Z, Wang G. Identification of iron metabolism-related predictive markers of endometriosis and endometriosis-relevant ovarian cancer. Medicine. 2023;102:e33478.","journal-title":"Medicine"},{"key":"1044_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1223493","volume":"10","author":"W Lai","year":"2023","unstructured":"Lai W, Chen J, Wang T, Liu Q. Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers. Front Mol Biosci. 2023;10:1223493.","journal-title":"Front Mol Biosci"},{"key":"1044_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106013","volume":"177","author":"H Ji","year":"2022","unstructured":"Ji H, Wang W, Li X, Han X, Zhang X, Wang J, et al. p53: a double-edged sword in tumor ferroptosis. Pharmacol Res. 2022;177:106013.","journal-title":"Pharmacol Res"},{"key":"1044_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216119","volume":"559","author":"J Lee","year":"2023","unstructured":"Lee J, Roh J-L. Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience. Cancer Lett. 2023;559:216119.","journal-title":"Cancer Lett"},{"key":"1044_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res. 2024;43:108.","journal-title":"J Exp Clin Cancer Res"},{"key":"1044_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202401449","volume":"9","author":"S Shruthi","year":"2024","unstructured":"Shruthi S, Bhasker Shenoy K. Cisplatin resistance in cancer therapy: causes and overcoming strategies. ChemistrySelect. 2024;9:e202401449.","journal-title":"ChemistrySelect"},{"key":"1044_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1519046","volume":"14","author":"H Peng","year":"2024","unstructured":"Peng H, Dou H, He S, Xie Y-A, Zhang Q, Zheng J. The role of GOT1 in cancer metabolism. Front Oncol. 2024;14:1519046.","journal-title":"Front Oncol"},{"key":"1044_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7150\/ijbs.81609","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Sun Y, Guo Y, Shi X, Chen X, Feng W, et al. An overview: the diversified role of mitochondria in cancer metabolism. Int J Biol Sci. 2023;19:897.","journal-title":"Int J Biol Sci"},{"key":"1044_CR17","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.3390\/cells11233893","volume":"11","author":"Y Guo","year":"2022","unstructured":"Guo Y, Chen T, Liang X, Gou S, Xiong J, Cui J, et al. Tumor cell derived exosomal GOT1 suppresses tumor cell ferroptosis to accelerate pancreatic cancer progression by activating Nrf2\/HO-1 axis via upregulating CCR2 expression. Cells. 2022;11:3893.","journal-title":"Cells"},{"key":"1044_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00109-022-02181-8","volume":"100","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zheng M, Han F, Shang L, Li M, Gu X, et al. Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming. J Mol Med. 2022;100:599\u2013612.","journal-title":"J Mol Med"},{"key":"1044_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.929832","volume":"9","author":"J Wu","year":"2022","unstructured":"Wu J, Zhang L, Wu S, Liu Z. Ferroptosis: opportunities and challenges in treating endometrial cancer. Front Mol Biosci. 2022;9:929832.","journal-title":"Front Mol Biosci"},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. methods. 2001;25:402\u20138.","journal-title":"methods"},{"key":"1044_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01550-9","volume":"22","author":"Z Yu","year":"2024","unstructured":"Yu Z, Zhang Q, Wei S, Zhang Y, Zhou T, Zhang Q, et al. CD146+ CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10\/JAK1\/STAT3 pathway. Cell Commun Signal. 2024;22:170.","journal-title":"Cell Commun Signal"},{"key":"1044_CR22","doi-asserted-by":"publisher","first-page":"e31159","DOI":"10.1097\/MD.0000000000031159","volume":"101","author":"S Hu","year":"2022","unstructured":"Hu S, Gan H, Yang F. Significance analysis of PAX8 expression in endometrial carcinoma. Medicine. 2022;101:e31159.","journal-title":"Medicine"},{"key":"1044_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00889-3","volume":"12","author":"H Russell","year":"2020","unstructured":"Russell H, Kedzierska K, Buchanan DD, Thomas R, Tham E, Mints M, et al. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability. Clin Epigenet. 2020;12:1\u20139.","journal-title":"Clin Epigenet"},{"key":"1044_CR24","first-page":"334","volume":"29","author":"F Sun","year":"2023","unstructured":"Sun F, Zhou J, Hao Y, Kuang L, Zhang B. MET inhibits the proliferation of EC cells by increasing MPA sensitivity. Altern Ther Heal Med. 2023;29:334\u201341.","journal-title":"Altern Ther Heal Med"},{"key":"1044_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/10715762.2021.1876856","volume":"55","author":"X Chen","year":"2021","unstructured":"Chen X, Li X, Xu X, Li L, Liang N, Zhang L, et al. Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation. Free Radic Res. 2021;55:405\u201315.","journal-title":"Free Radic Res"},{"key":"1044_CR26","doi-asserted-by":"crossref","unstructured":"Jing L, Xiao W, Hu Z, Liu X, Yuan M A. Systematic review of nanoparticle-mediated ferroptosis in glioma therapy. Int J Nanomed. 2025:5779\u201397.","DOI":"10.2147\/IJN.S523008"},{"key":"1044_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/antiox13060659","volume":"13","author":"T Xie","year":"2024","unstructured":"Xie T, Yao L, Li X. Advance in iron metabolism, oxidative stress and cellular dysfunction in experimental and human kidney diseases. Antioxidants. 2024;13:659.","journal-title":"Antioxidants"},{"key":"1044_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/10715762.2023.2244155","volume":"57","author":"J Fujii","year":"2023","unstructured":"Fujii J, Yamada K-i. Defense systems to avoid ferroptosis caused by lipid peroxidation-mediated membrane damage. Free Radic Res. 2023;57:353\u201372.","journal-title":"Free Radic Res"},{"key":"1044_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.861142","volume":"12","author":"R Yi","year":"2022","unstructured":"Yi R, Xie L, Wang X, Shen C, Chen X, Qiao L. Multi-omic profiling of multi-biosamples reveals the role of amino acid and nucleotide metabolism in endometrial cancer. Front Oncol. 2022;12:861142.","journal-title":"Front Oncol"},{"key":"1044_CR30","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/CMAR.S278728","volume":"13","author":"H Wang","year":"2021","unstructured":"Wang H, Peng S, Cai J, Bao S. Silencing of PTPN18 induced ferroptosis in endometrial cancer cells through p-P38-mediated GPX4\/xCT down-regulation. Cancer Manag Res. 2021;13:1757\u201365.","journal-title":"Cancer Manag Res"},{"key":"1044_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3892\/ol.2025.14901","volume":"29","author":"C Ma","year":"2025","unstructured":"Ma C, He Y, Wang J, Zhang J, Hou X, Wang S, et al. Expression levels of STAT3, and protein levels of IL\u20116 and sPD\u2011L1 in different pathological characteristics of endometrial adenocarcinomas. Oncol Lett. 2025;29:156.","journal-title":"Oncol Lett"},{"key":"1044_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s12094-022-02970-0","volume":"25","author":"J Chen","year":"2023","unstructured":"Chen J, Huang S, Li H, Li Y, Zeng H, Hu J, et al. STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration. Clin Transl Oncol. 2023;25:662\u201372.","journal-title":"Clin Transl Oncol"},{"key":"1044_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102317","volume":"52","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317.","journal-title":"Redox Biol"},{"key":"1044_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong M, Zhang W, Mo J, Zhang S, Zhu Z, et al. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis. 2022;13:630.","journal-title":"Cell Death Dis"},{"key":"1044_CR35","doi-asserted-by":"publisher","first-page":"e936727","DOI":"10.12659\/MSM.936727","volume":"28","author":"RA Bender","year":"2022","unstructured":"Bender RA. Medroxyprogesterone acetate for abnormal uterine bleeding due to ovulatory dysfunction: the effect of 2 different-duration regimens. Med Sci Monit: Int Med J Exp Clin Res. 2022;28:e936727\u20131.","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"key":"1044_CR36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1152\/physrev.00031.2019","volume":"100","author":"HOD Critchley","year":"2020","unstructured":"Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Physiology of the endometrium and regulation of menstruation. Physiol Rev. 2020;100:1149\u201379.","journal-title":"Physiol Rev"},{"key":"1044_CR37","doi-asserted-by":"publisher","first-page":"e035416","DOI":"10.1136\/bmjopen-2019-035416","volume":"10","author":"A Mitsuhashi","year":"2020","unstructured":"Mitsuhashi A, Kawasaki Y, Hori M, Fujiwara T, Hanaoka H, Shozu M. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial). BMJ Open. 2020;10:e035416.","journal-title":"BMJ Open"},{"key":"1044_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121753","volume":"325","author":"H Murakami","year":"2023","unstructured":"Murakami H, Hayashi M, Terada S, Ohmichi M. Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. Life Sci. 2023;325:121753.","journal-title":"Life Sci"},{"key":"1044_CR39","doi-asserted-by":"publisher","first-page":"75.","DOI":"10.3390\/ijms25010075","volume":"25","author":"E \u017dalyt\u0117","year":"2023","unstructured":"\u017dalyt\u0117 E. Ferroptosis, metabolic rewiring, and endometrial cancer. Int J Mol Sci. 2023;25:75.","journal-title":"Int J Mol Sci"},{"key":"1044_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107902","volume":"219","author":"X Li","year":"2025","unstructured":"Li X, Wang Y, Wu Y, Wang J, Qi Y, Bi X, et al. Intratumor microbiome-derived butyrate enhances progesterone sensitivity by inducing ferroptosis in endometrial cancer. Pharmacol Res. 2025;219:107902.","journal-title":"Pharmacol Res"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01044-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01044-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01044-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:49:45Z","timestamp":1786448985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01044-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01044-5","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ethics Committee of Hefei Comprehensive National Science Center for Health and Medicine (approval number: IHM-API-2025-113) and the Medical Ethics Committee of Shanghai First Maternity and Infant Health Hospital (approval number: KS25340). All procedures involving human participants and animals were conducted in accordance with relevant ethical guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all subjects.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}